218 related articles for article (PubMed ID: 33437990)
21. Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus.
Wei Q; Jiang Y; Xiao M; Zhang X; Qi J; Xie J; Wu J; Wu Z; Gu J
Scand J Immunol; 2020 Mar; 91(3):e12849. PubMed ID: 31899559
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
23. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
[TBL] [Abstract][Full Text] [Related]
24. The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence.
Ou Y; Enarson P; Rattner JB; Barr SG; Fritzler MJ
Clin Exp Immunol; 2004 May; 136(2):379-87. PubMed ID: 15086405
[TBL] [Abstract][Full Text] [Related]
25. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
[TBL] [Abstract][Full Text] [Related]
26. [Antinuclear antibodies in systemic autoimmune disease].
Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
[TBL] [Abstract][Full Text] [Related]
27. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
[TBL] [Abstract][Full Text] [Related]
28. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
[TBL] [Abstract][Full Text] [Related]
30. Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus.
Rasmussen A; Radfar L; Lewis D; Grundahl K; Stone DU; Kaufman CE; Rhodus NL; Segal B; Wallace DJ; Weisman MH; Venuturupalli S; Kurien BT; Lessard CJ; Sivils KL; Scofield RH
Rheumatology (Oxford); 2016 Jul; 55(7):1195-201. PubMed ID: 26998859
[TBL] [Abstract][Full Text] [Related]
31. The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients.
Santos WFS; Cantuária APC; Félix DC; Nardes LK; de Melo ICS
Adv Rheumatol; 2022 Aug; 62(1):32. PubMed ID: 35971154
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
Hietarinta M; Lassila O
Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
[TBL] [Abstract][Full Text] [Related]
33. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
34. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
35. The autoimmune diseases.
Condemi JJ
JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
[No Abstract] [Full Text] [Related]
36. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
Ulvestad E; Kanestrøm A; Madland TM; Thomassen E; Haga HJ; Vollset SE
Scand J Immunol; 2000 Sep; 52(3):309-15. PubMed ID: 10972909
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
38. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate.
Tanaka N; Muro Y; Sugiura K; Tomita Y
Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690
[TBL] [Abstract][Full Text] [Related]
39. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
40. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis.
Maslyanskiy A; Lazareva N; Olinek P; Schierack P; Hentschel C; Cuccato J; Bogdanos DP; Lapin SV; Roggenbuck D
J Immunol Res; 2014; 2014():516593. PubMed ID: 24883333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
